Over the past two decades, our ability to rapidly obtain genomic information on an individual and their cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs has led to a dramatic shift in how we can diagnose, treat, monitorto check on, keep track of and prevent cancer, leading to an era of precision oncologythe study, diagnosis and treatment of cancer.
With this expanded knowledge of cancer there are several promising treatments that can specifically target the drivers of an individual’s cancer, that are already under review through Australia’s health technology assessment process. Too many people living with cancer in Australia still don’t have access; and they can’t afford to wait.